BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/17/2015 8:51:00 AM | Browse: 429 | Download: 465
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 19083
Country/Territory Germany
Received
2015-04-29 13:17
Peer-Review Started
2015-05-07 10:33
To Make the First Decision
2015-06-25 17:44
Return for Revision
2015-06-26 19:45
Revised
2015-07-23 14:47
Second Decision
2015-09-28 16:09
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2015-10-09 10:59
Articles in Press
2015-10-09 10:59
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-10-27 21:27
Publish the Manuscript Online
2015-11-17 08:51
ISSN 1948-5204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Biochemistry and Molecular Biology
Manuscript Type Topic Highlights
Article Title Individualized treatment of gastric cancer: Impact of molecular biology and pathohistological features
Manuscript Source Invited Manuscript
All Author List Yves Dittmar and Utz Settmacher
Funding Agency and Grant Number
Corresponding author Yves Dittmar, MD, Department of General, Visceral and Vascular Surgery, University Hospital Jena, Erlanger Allee 101, 07745 Jena, Germany. yves.dittmar@med.uni-jena.de
Keywords Gastric cancer; Molecular biology; Targeted therapy; Personalized medicine; Signaling pathway
Core Tip Advanced gastric cancer remains a frequent malignancy with poor prognosis despite multimodal treatment options. Surgery alone has been demonstrated not to be the optimal strategy and is predominantly limited to cases without distant metastases. About one half of gastric cancer patients cannot be cured. Due to its individual heterogeneity on the molecular level these tumors frequently do not respond to systemic treatment. The implementation of the growing knowledge about the molecular behavior of gastric cancer in the development or improvement of target-specific treatment strategies might be one of the major challenges for the next decades.
Publish Date 2015-11-17 08:51
Citation Dittmar Y, Settmacher U. Individualized treatment of gastric cancer: Impact of molecular biology and pathohistological features. World J Gastrointest Oncol 2015; 7(11): 292-302
Url http://www.wjgnet.com/1948-5204/full/v7/i11/292.htm
DOI http://dx.doi.org/10.4251/wjgo.v7.i11.292
Full Article (PDF) WJGO-7-292.pdf
Full Article (Word) WJGO-7-292.doc
Manuscript File 19083-Review.doc
Answering Reviewers 19083-Answering reviewers.pdf
Audio Core Tip 19083-Audio core tip.wav
Peer-review Report 19083-Peer-review(s).pdf
Scientific Misconduct Check 19083-Scientific misconduct check.pdf
Scientific Editor Work List 19083-Scientific editor work list.pdf